Sponsor intelligence · INDUSTRY

Clinical trials sponsored by
Sichuan Baili Pharmaceutical Co., Ltd..

Real, source-linked trial activity for Sichuan Baili Pharmaceutical Co., Ltd.: 11 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.

✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 26, 2026. Source-linked, daily-refreshed.

PHASE1/PHASE2 3PHASE1 3PHASE2 2PHASE2/PHASE3 2PHASE3 1

Newest Sichuan Baili Pharmaceutical Co., Ltd. trials

PostedTrialPhaseStatus
1d ago A Study of BL-M08D in Patients With Locally Advanced or Metastatic Mel Ph 1/Ph 2 NOT_YET_RECRUITING ↗
12d ago A Study of BL-M08D1 in Combination With Immunochemotherapy in Patients Ph 1/Ph 2 NOT_YET_RECRUITING ↗
25d ago A Study of BL-B01D1 With or Without PD-1 Monoclonal Antibody in Patien Ph 2 NOT_YET_RECRUITING ↗
30d ago A Study of BL-M08D1 in Patients With Recurrent or Metastatic Head and Ph 2 NOT_YET_RECRUITING ↗
36d ago A Study of BL-M08D in Patients With Locally Advanced or Metastatic Dig Ph 1/Ph 2 NOT_YET_RECRUITING ↗
36d ago A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gyn Ph 1 NOT_YET_RECRUITING ↗
50d ago A Study of SI-B036 in Patients With Locally Advanced or Metastatic Bre Ph 1 NOT_YET_RECRUITING ↗
53d ago A Study of SI-B036 in Patients With Locally Advanced or Metastatic Uro Ph 1 NOT_YET_RECRUITING ↗
57d ago A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific An Ph 2/Ph 3 NOT_YET_RECRUITING ↗
57d ago A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Ph 2/Ph 3 NOT_YET_RECRUITING ↗
60d ago A Study of BL-B01D1 Plus an Anti-PD-1 Antibody Versus Nab-paclitaxel P Ph 3 NOT_YET_RECRUITING ↗

Get this lane pushed to you the day a new grant or trial lands

Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Sichuan Baili Pharmaceutical Co., Ltd. (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.